Scholarlink

Background <p>Heart failure (HF) is a fast-growing public health concern that is linked to substantial morbidity and mortality as well as a poor quality of life. There is no specific biomarker that can be used to detect early HF with preserved ejection fraction (EF). MicroRNAs (miRs) are known to be involved in the development of HF.</p> Aim <p>To investigate the plasma level of miR-19b, miR-21, and miR-208a and their relevance in early diagnosis of HF.</p> Subjects and methods <p>In this study, 120 participants were divided into four groups: 30 controls in Group I, 30 HF patients with preserved EF in Group II, 30 HF patients with mildly reduced EF (HFmrEF) in Group III, and 30 HF patients with reduced EF (HFrEF) in Group IV. Real-time PCR was used to examine the expression levels of miR-19b, miR-21, and miR-208a, and ELISA was used to assess the NT-proBNP level.</p> Results <p>Compared to controls, HF patients' groups exhibited a substantial sequential rise in miR-21 and miR-208a expression (<i>p</i> &lt; 0.001). However, HF patients had considerably lower levels of miR-19b expression compared to controls (<i>p</i> &lt; 0.001). The cutoff value of miR-19b to discriminate HFmrEF from HFpEF was 11.2 (93.3% sensitivity, 86.7% specificity) (<i>p</i> &lt; 0.001). In contrast, miR-21 had a cutoff value of 5.5 (70% sensitivity and 76.7% specificity), and miR-208a had a cutoff point of &gt; 10.3 (93.3% sensitivity and 93.3% specificity).</p> Conclusion <p>MiR-19b, miR-208a and miR-21 could be useful biomarkers with high sensitivity and specificity for early detection of HF and in discrimination between HFmrEF and HFpEF.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The Role of microRNA-19b, microRNA-21, and microRNA-208a in diagnosis of heart failure

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月1日

查看全文
  • Waleed M. Fathy,
  • Belal A. Montaser,
  • Waleed A. Ibrahim,
  • Doaa M. Salah,
  • Noran T. Aboelkhair

摘要

Background

Heart failure (HF) is a fast-growing public health concern that is linked to substantial morbidity and mortality as well as a poor quality of life. There is no specific biomarker that can be used to detect early HF with preserved ejection fraction (EF). MicroRNAs (miRs) are known to be involved in the development of HF.

Aim

To investigate the plasma level of miR-19b, miR-21, and miR-208a and their relevance in early diagnosis of HF.

Subjects and methods

In this study, 120 participants were divided into four groups: 30 controls in Group I, 30 HF patients with preserved EF in Group II, 30 HF patients with mildly reduced EF (HFmrEF) in Group III, and 30 HF patients with reduced EF (HFrEF) in Group IV. Real-time PCR was used to examine the expression levels of miR-19b, miR-21, and miR-208a, and ELISA was used to assess the NT-proBNP level.

Results

Compared to controls, HF patients' groups exhibited a substantial sequential rise in miR-21 and miR-208a expression (p < 0.001). However, HF patients had considerably lower levels of miR-19b expression compared to controls (p < 0.001). The cutoff value of miR-19b to discriminate HFmrEF from HFpEF was 11.2 (93.3% sensitivity, 86.7% specificity) (p < 0.001). In contrast, miR-21 had a cutoff value of 5.5 (70% sensitivity and 76.7% specificity), and miR-208a had a cutoff point of > 10.3 (93.3% sensitivity and 93.3% specificity).

Conclusion

MiR-19b, miR-208a and miR-21 could be useful biomarkers with high sensitivity and specificity for early detection of HF and in discrimination between HFmrEF and HFpEF.